159 related articles for article (PubMed ID: 21402072)
1. Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression.
Victoriano AF; Imai K; Togami H; Ueno T; Asamitsu K; Suzuki T; Miyata N; Ochiai K; Okamoto T
FEBS Lett; 2011 Apr; 585(7):1103-11. PubMed ID: 21402072
[TBL] [Abstract][Full Text] [Related]
2. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
Quivy V; De Walque S; Van Lint C
Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
[TBL] [Abstract][Full Text] [Related]
4. Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1.
Choi BS; Lee HS; Oh YT; Hyun YL; Ro S; Kim SS; Hong KJ
AIDS; 2010 Feb; 24(4):609-11. PubMed ID: 20154582
[TBL] [Abstract][Full Text] [Related]
5. The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response.
Bernhard W; Barreto K; Saunders A; Dahabieh MS; Johnson P; Sadowski I
FEBS Lett; 2011 Nov; 585(22):3549-54. PubMed ID: 22020221
[TBL] [Abstract][Full Text] [Related]
6. c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter.
Jiang G; Espeseth A; Hazuda DJ; Margolis DM
J Virol; 2007 Oct; 81(20):10914-23. PubMed ID: 17670825
[TBL] [Abstract][Full Text] [Related]
7. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
Zhao S; Venkatasubbarao K; Li S; Freeman JW
Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
[TBL] [Abstract][Full Text] [Related]
8. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.
Lusic M; Marcello A; Cereseto A; Giacca M
EMBO J; 2003 Dec; 22(24):6550-61. PubMed ID: 14657027
[TBL] [Abstract][Full Text] [Related]
9. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
Zhang HS; Ruan Z; Sang WW
J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells.
Lin S; Zhang Y; Ying H; Zhu H
Curr HIV Res; 2011 Jun; 9(4):202-8. PubMed ID: 21631428
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of HIV-1 transcription.
Tripathy MK; Abbas W; Herbein G
Epigenomics; 2011 Aug; 3(4):487-502. PubMed ID: 22126207
[TBL] [Abstract][Full Text] [Related]
12. The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells.
Shehu-Xhilaga M; Rhodes D; Wightman F; Liu HB; Solomon A; Saleh S; Dear AE; Cameron PU; Lewin SR
AIDS; 2009 Sep; 23(15):2047-50. PubMed ID: 19609198
[TBL] [Abstract][Full Text] [Related]
13. Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat.
He G; Margolis DM
Mol Cell Biol; 2002 May; 22(9):2965-73. PubMed ID: 11940654
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor MC1293 induces latent HIV-1 reactivation by histone modification in vitro latency cell lines.
Qu X; Ying H; Wang X; Kong C; Zhou X; Wang P; Zhu H
Curr HIV Res; 2013 Jan; 11(1):24-9. PubMed ID: 23092175
[TBL] [Abstract][Full Text] [Related]
15. Involvement of chromatin and histone acetylation in the regulation of HIV-LTR by thyroid hormone receptor.
Hsia SC; Wang H; Shi YB
Cell Res; 2001 Mar; 11(1):8-16. PubMed ID: 11305329
[TBL] [Abstract][Full Text] [Related]
16. Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.
Choudhary SK; Archin NM; Margolis DM
J Infect Dis; 2008 Apr; 197(8):1162-70. PubMed ID: 18419522
[TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
[TBL] [Abstract][Full Text] [Related]
18. Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies.
Demonté D; Quivy V; Colette Y; Van Lint C
Biochem Pharmacol; 2004 Sep; 68(6):1231-8. PubMed ID: 15313421
[TBL] [Abstract][Full Text] [Related]
19. The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events.
Lucera MB; Tilton CA; Mao H; Dobrowolski C; Tabler CO; Haqqani AA; Karn J; Tilton JC
J Virol; 2014 Sep; 88(18):10803-12. PubMed ID: 25008921
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
